Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing

Documenti analoghi

• Metabolic Characterization of Vamorolone in Human Liver Microsomes: Implications for Anti‐Doping
  di: Zhongquan Li, et al.
  Pubblicazione: (2024)
• The Evolution of Precision Anti‐Doping From UGT2B17 Polymorphism Insights to Integrated Detection Frameworks
  di: Jiahui Cheng, et al.
  Pubblicazione: (2026)
• Identification of Metabolites of the Dietary Supplement Ingredient 5α‐Hydroxy‐Laxogenin
  di: Daniel Derwand, et al.
  Pubblicazione: (2026)
• New Metabolites of Methyldienolone by In Vitro Human Liver Microsomes and Characterized Using LC/HRMS for Doping Control Purposes
  di: Jinghua Hou, et al.
  Pubblicazione: (2025)
• Investigation Into the Equine Metabolism of Phosphodiesterase‐4 Inhibitor Roflumilast for Potential Doping Control
  di: Moses Philip, et al.
  Pubblicazione: (2024)